New modeling released today by the University of Sydney’s Brain and Mind Centre combines productivity and suicide data, demonstrating the benefits of acting urgently and […]
Epizyme Announces Registration Path for Tazemetostat for Follicular Lymphoma and Provides Pipeline Updates and 2019 Guidance
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Jan. 4, 2019– Epizyme, Inc. (Nasdaq: EPZM), a clinical-stage company developing novel epigenetic therapies, today announced a comprehensive set of pipeline updates, including […]